New device could get heart patients walking faster after procedure
NCT ID NCT07414121
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a special closure device (VASCADE MVP) to stop bleeding after a heart ablation for atrial fibrillation. The goal is to see if it helps patients get up and walk sooner compared to standard manual compression. One hundred adults undergoing ablation will be randomly assigned to either the device or standard care, and recovery time will be measured.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
VASCADE MVP vascular closure device
What this could lead to
If successful, this device could help patients get out of bed faster after heart ablation procedures, reducing discomfort and hospital stay.
What could go wrong
This is a small early-stage study (100 patients) focused on recovery speed, not on treating atrial fibrillation itself. The device may not prove safer or more effective than standard methods.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ATRIAL FIBRILLATION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Asklepios Klinik Altona
RECRUITINGHamburg, Germany
Contact Phone: •••-•••-•••• Email: •••••@•••••